Skip to main content
An official website of the United States government

devimistat

A racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, devimistat has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.
Synonym:alpha-lipoic acid analogue CPI-613
Code name:CPI 613
CPI-613
Search NCI's Drug Dictionary